论文部分内容阅读
This retrospective analysis compared standard regimen of doxorubicin, bleomycin, vinblastine, and dacarbazine(ABVD) with the dose-dense ABVD regimen(ABVD-21) in terms of efficacy and toxicity. Patients who had early-stage unfavorable or advanced Hodgkin’s